Deutsche Bank analysts downgraded Intuitive Surgical stock (NASDAQ: NASDAQ: ISRG) from a Hold to a Sell rating. The analysts also adjusted the price target to $440 from the previous $515, placing it ...

The company recently revealed that the FDA has recently cleared Intuitive’s da Vinci SP system for transanal local excision/resection, a minimally invasive surgery done without abdominal cuts.

Background: Recent non-randomized studies suggest that extended endoscopic mucosal resection (EMR) is equally effective in removing large rectal adenomas as transanal endoscopic microsurgery (TEM).

Despite the recent fall in share price, ISRG’s shares are up 6.9%, outperforming the Zacks Medical - Instruments industry’s ...

Transanal Minimally Invasive Surgery (TAMIS ... TAMIS platform is versatile and there are some applications beyond local excision. There are descriptions of rectourethral fistula repair, ligation of ...

Earlier this month, the US FDA cleared the da Vinci Single Port surgical system for transanal local excision/resection, thus helping to extend the system’s capabilities in colorectal surgery. Boston ...

excision of a sebaceous cyst, transanal excision of a rectal polyp and excision of a hypertrophic papilla. There was neither mortality nor any life-threatening morbidity. Intraoperative complications ...

Excision BioTherapeutics, Inc. (Excision), a biotechnology company developing CRISPR-based therapies to cure viral infectious diseases, announced publication of a preprint demonstrating ...